000 01718 a2200457 4500
005 20250518091855.0
264 0 _c20210511
008 202105s 0 0 eng d
022 _a1573-7365
024 7 _a10.1007/s11011-020-00551-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKeshk, Walaa A
245 0 0 _aCurcumin attenuates cytoplasmic/endoplasmic reticulum stress, apoptosis and cholinergic dysfunction in diabetic rat hippocampus.
_h[electronic resource]
260 _bMetabolic brain disease
_c04 2020
300 _a637-647 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aActivating Transcription Factor 4
_xgenetics
650 0 4 _aAnimals
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aBlood Glucose
_xmetabolism
650 0 4 _aCholine O-Acetyltransferase
_xgenetics
650 0 4 _aCurcumin
_xpharmacology
650 0 4 _aDiabetes Mellitus, Experimental
_xgenetics
650 0 4 _aEndoplasmic Reticulum Stress
_xdrug effects
650 0 4 _aHSP70 Heat-Shock Proteins
_xmetabolism
650 0 4 _aHeat-Shock Proteins
_xgenetics
650 0 4 _aHippocampus
_xdrug effects
650 0 4 _aInterferon-gamma
_xmetabolism
650 0 4 _aMale
650 0 4 _aProtective Agents
_xpharmacology
650 0 4 _aProto-Oncogene Proteins c-bcl-2
_xgenetics
650 0 4 _aRats
650 0 4 _aRats, Wistar
650 0 4 _aTranscription Factor CHOP
_xmetabolism
650 0 4 _abcl-2-Associated X Protein
_xmetabolism
700 1 _aElseady, Walaa S
700 1 _aSarhan, Naglaa I
700 1 _aZineldeen, Doaa H
773 0 _tMetabolic brain disease
_gvol. 35
_gno. 4
_gp. 637-647
856 4 0 _uhttps://doi.org/10.1007/s11011-020-00551-0
_zAvailable from publisher's website
999 _c30742705
_d30742705